2025-10-10T12:05:42-05:00 2024-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2024-01-01 943240841 AIDS VACCINE ADVOCACY COALITION INC AIDS 2127966423 125 BROAD STREET FL9 NEW YORK NY 10004 ABIGAIL SMITH CFO 9175435720 2025-10-08 1 0 WILLIAM EPSTEIN P01307171 2129498700 2024 2025-03-06 01:10:19Z MITCHELL WARREN 125 BROAD STREET FL9 NEW YORK NY 10004 10029156 0 X WWW.AVAC.ORG X 1995 DE ACCELERATE THE ETHICAL DEVELOPMENT OF EFFECTIVE HIV (CONTINUED ON SCHEDULE O)CONTINUED: PREVENTION OPTIONS AND ENSURE ACCESS TO THOSE OPTIONS FOR EVERYONE WHO NEEDS THEM AS PART OF A COMPREHENSIVE INTEGRATED PATH TO GLOBAL HEALTH EQUITY. 16 15 37 0 0 0 14736289 9955666 0 0 74511 62232 2446 11258 14813246 10029156 4380196 3019690 0 0 6820208 7754915 0 0 35006 3281211 3016525 14481615 13791130 331631 -3761974 7924437 3854652 1205868 894872 6718569 2959780 X ACCELERATE THE ETHICAL DEVELOPMENT OF EFFECTIVE HIV PREVENTION OPTIONS AND ENSURE ACCESS TO THOSE OPTIONS FOR EVERYONE WHO NEEDS THEM AS PART OF A COMPREHENSIVE INTEGRATED PATH TO GLOBAL HEALTH EQUITY. 0 0 4431753 2027385 RESEARCH ENGAGEMENT AND PREPAREDNESS: RESEARCH PREPAREDNESS IS DESIGNED TO SHAPE THE R&D ENVIRONMENT THROUGH ADVOCACY FOR INVESTMENT, POLITICAL SUPPORT, AND GOOD PARTICIPATORY PRACTICE. AVAC TRACKS AND TRANSLATES BOTH COMMUNITY ADVOCACY AND COMPLEX SCIENCE TO MAKE THE SCIENCE ACCESSIBLE AND POSITION COMMUNITY PRIORITIES AT THE CENTER OF GLOBAL HEALTH. AVAC IMPROVED TRIAL DESIGN AND CONDUCT BY BRINGING TOGETHER RESEARCHERS, TRIAL SITE STAFF, CIVIL SOCIETY, POLICYMAKERS, TRIAL PARTICIPANTS, AND COMMUNITIES TO CENTER PERSPECTIVES OF AFFECTED COMMUNITIES IN RESEARCH. AVAC DEVELOPED MATERIALS AND DOCUMENTS RELATING TO THE PREVENTION OF HIV/AIDS; CONVENED MULTIPLE MEETINGS WITH STAKEHOLDERS SUCH AS RESEARCHERS AND CIVIL SOCIETY LEADERS TO DISCUSS RESEARCH FINDINGS; PROGRAM SERVICE ACCOMPLISHMENTS. 2151615 629841 PRODUCT INTRODUCTION AND ACCESS: THE PRODUCT INTRODUCTION PROGRAM IS DESIGNED TO IDENTIFY AND ANTICIPATE NEEDS AND GAPS AND PROVIDE TARGETED TOOLS, SUPPORT AND PLATFORMS TO EXPAND ACCESS TO HIV/AIDS PREVENTION. THE PROGRAM FOCUSES ON: SUCCESSFUL SCALE-UP AND INTRODUCTION IN THREE PRIORITY COUNTRIES FROM THE OUTSET; DEVELOP ADAPTABLE AND SCALABLE TOOLS TO SUPPORT OTHER COUNTRIES; SUPPORT THE DEVELOPMENT OF MARKETABLE PRODUCTS IN THE HIV PREVENTION AND SEXUAL AND REPRODUCTIVE HEALTH RESEARCH PIPELINE; AND CREATE A FLEXIBLE MECHANISM TO ASSIST PRODUCT DEVELOPERS, FUNDERS AND COUNTRY PROGRAMS TO IDENTIFY AND ADDRESS BARRIERS TO IMPROVED PRODUCTS AND ACCELERATED INTRODUCTION. PROJECTS ARE IMPLEMENTED IN COLLABORATION WITH A NETWORK OF FUNDERS, (CONTINUED ON SCHEDULE O)CONTINUED: PRODUCT DEVELOPERS AND GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS INCLUDING THE BILL AND MELINDA GATES FOUNDATION, CHILDRENS INVESTMENT FUND FOUNDATION, WORLD HEALTH ORGANIZATION, POPULATION COUNCIL, VIATRIS, MANN GLOBAL HEALTH, MEDICINES360, USAID, CATALYST GLOBAL, HIV PREVENTION TRIALS NETWORK, AND CLINTON HEALTH ACCESS INITATIVE. 1539759 362464 GLOBAL MOVEMENT BUILDING: GLOBAL MOVEMENT BUILDING CULTIVATES THE NEXT GENERATION OF ADVOCATES VIA THE AVAC FELLOWS AND ADVOCACY NAVIGATOR PROGRAMS. ADVOCATES ARE EQUIPPED WITH THE SKILLS, OPPORTUNITIES AND ACCESS TO DRIVE CHANGE IN HIV PREVENTION AND GLOBAL HEALTH EQUITY BY AMPLIFYING COMMUNITY VOICES AND INFLUENCING POLICY AND RESEARCH. ALUMNI OF THESE PROGRAMS ARE LEADING, INTERNATIONALLY RECOGNIZED CIVIL SOCIETY ADVOCATES. THEY HAVE GONE ON TO FOUND CIVIL SOCIETY ORGANIZATIONS, INFLUENCE THE HIV PREVENTION RESEARCH PIPELINE, AND SHAPE CONVERSATIONS AND OBJECTIVES IN THE FIELD. AVAC ALSO SHAPES THE MEDIA ENVIRONMENT BY COLLABORATING CLOSELY WITH JOURNALIST CONVENERS TO BRING TOGETHER JOURNALISTS AND SCIENTISTS AT MEDIA SCIENCE CAFES. THROUGH THIS ENGAGEMENT WITH EXPERTS, (CONTINUED ON SCHEDULE O)CONTINUED: LOCAL JOURNALISTS HAVE DIRECT ACCESS TO ACCURATE DATA AND INFORMATION, ENABLING THEM TO TRANSLATE THE SCIENCE AND REPORT DIRECTLY TO LOCAL COMMUNITIES ON DEVELOPMENTS IN HIV BIOMEDICAL PREVENTION RESEARCH. THIS IMPROVES THE QUALITY AND ACCURACY OF REPORTING, COMBATS MISINFORMATION, AND BRINGS VISIBILITY TO RESEARCH DEVELOPMENTS. 3076975 0 PROGRAMS ARE POLICY ADVOCACY AND PROGRAM MANAGEMENT AND COMMUNICATIONS 3076975 0 11200102 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 22 0 37 1 0 0 0 0 0 0 0 0 0 0 0 0 X 16 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NY X X ABIGAIL SMITH CFO 9175435720 125 BROAD STREET FL9 NEW YORK NY 10004 MITCHELL WARREN EXECUTIVE DIRECTOR 50.00 X X 400812 0 47503 BLAIR HANEWALL PRESIDENT 1.00 X X 0 0 0 KELLY MCKAIG TREASURER 1.00 X X 0 0 0 YVONNE MUTHONI SECRETARY 1.00 X X 0 0 0 CATE HANKINS BOARD MEMBER 1.00 X 0 0 0 ADRIAN MCDERMOTT BOARD MEMBER 1.00 X 0 0 0 DEONDRE MOORE BOARD MEMBER 1.00 X 0 0 0 JEFF O'MALLEY BOARD MEMBER 1.00 X 0 0 0 JESSE MILAN BOARD MEMBER 1.00 X 0 0 0 JINTANAT ANANWORANICH BOARD MEMBER 1.00 X 0 0 0 LEIGH ANN VAN DER MERWE BOARD MEMBER 1.00 X 0 0 0 LINDA-GAIL BEKKER BOARD MEMBER 1.00 X 0 0 0 MARINA CASKEY BOARD MEMBER 1.00 X 0 0 0 NYARADZO MGODI BOARD MEMBER 1.00 X 0 0 0 SOLANGE BAPTISTE BOARD MEMBER 1.00 X 0 0 0 SUSIE MCLEAN BOARD MEMBER 1.00 X 0 0 0 ERIN KIERNON CHIEF OPERATING OFFICER 40.00 X 253516 0 64419 ABIGAIL SMITH CHIEF FINANCIAL OFFICER 40.00 X 237388 0 65924 STACEY HUMPHRIES DIRECTOR, RESEARCH ENGAGEMENT 40.00 X 188580 0 64004 MANJU CHATANI-GADA DIRECTOR, PARTNERSHIPS 40.00 X 191190 0 47348 SURAJKUMAR MADOORI DIRECTOR, POLICY ADVOCACY 40.00 X 175549 0 63584 KENYON FARROW DIRECTOR, COMMUNICATIONS 40.00 X 172382 0 26666 WANDA BUCKNER DIRECTOR, FINANCE 40.00 X 169312 0 60370 1788729 0 439818 22 0 1 0 KAY MARSHALL 176 DEAN STREET BROOKLYN NY 11217 COMMUNICATION SERVICES 182215 JENNIFER BRUNET 2962 BURR STREET FAIRFIELD CT 06824 COMMUNICATION SERVICES 165844 ALLEGIANCE FUNDRAISING LLC PO BOX 9132 FARGO ND 58106 WEBSITE DESIGN SERVICES 128901 MAUREEN LUBA MILAMBE PO BOX 3251 LILONGWE MI POLICY ADVOCACY SERVICES 106246 4 5461966 4493700 9955666 62232 62232 OTHER INCOME 900099 11258 11258 11258 10029156 11258 0 62232 X 1040014 1040014 1979676 1979676 1069562 822737 246650 175 4826863 3712960 1113113 790 176764 135972 40763 29 1275114 980854 294051 209 406612 312777 93768 67 41767 41767 69179 69179 1168789 1021414 116212 31163 444887 82543 361475 869 62956 62956 588728 554958 33770 444351 412988 30372 991 REPORTS AND PUBLICATION 148587 138778 9096 713 PROCESSING FEES 47281 4431 42850 0 13791130 11200102 2556022 35006 968562 175154 4648493 2513729 2067254 413083 240128 249501 503185 7924437 3854652 829054 650788 180109 145822 196705 98262 1205868 894872 X 6718569 2959780 6718569 2959780 7924437 3854652 -3761974 3185 0 X 0 1 X 1 1 1 X 12217459 10786718 14776117 14736289 9955666 62472249 12217459 10786718 14776117 14736289 9955666 62472249 26102776 36369473 5666 2701 14271 74511 62232 159381 1469 387 587 2446 11258 16147 62647777 0.58050 0.52520 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 FUNDS RECEIVED IN ADVANCE 98262 98262 X 10070616 3185 38275 41460 10029156 0 10029156 13829405 38275 38275 13791130 0 13791130 PART X, LINE 2: AVAC IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF AVAC'S GENERAL TAX-EXEMPT STATUS, MANAGEMENT BELIEVES ASC TOPIC 740 HAS NOT HAD, AND IS NOT EXPECTED TO HAVE, A MATERIAL IMPACT ON AVAC'S FINANCIAL STATEMENTS. 1 SUB-SAHARAN AFRICA - MALAWI, ZAMBIA, TANZANIA, SOUTH AFRICA, UGANDA, KENYA 0 0 GRANTMAKING GLOBAL MOVEMENT 341196 SUB-SAHARAN AFRICA - MALAWI, SOUTH AFRICA, TANZANIA 0 0 GRANTMAKING POLICY ADVOCACY 27599 SUB-SAHARAN AFRICA - SOUTH AFRICA 0 0 GRANTMAKING PRODUCT INTRODUCTION 8550 SUB-SAHARAN AFRICA - MALAWI, ZAMBIA, TANZANIA, SOUTH AFRICA, UGANDA, KENYA 0 0 GRANTMAKING RESEARCH ENGAGEMENT 1511512 SOUTH ASIA 0 0 GRANTMAKING RESEARCH ENGAGEMENT 25000 EUROPE (INCLUDING ICELAND & GREENLAND) - UNITED KINGDOM 0 0 GRANTMAKING PRODUCT INTRODUCTION 65819 0 0 0 0 0 0 1979676 0 1979676 SUB-SAHARAN AFRICA - MALAWI POLICY ADVOCACY 15068 0 FMV SUB-SAHARAN AFRICA - TANZANIA POLICY ADVOCACY 7531 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA PRODUCT INTRODUCTION AND ACCESS 8550 0 FMV SUB-SAHARAN AFRICA - MALAWI GLOBAL MOVEMENT 30827 0 FMV SUB-SAHARAN AFRICA - ZAMBIA GLOBAL MOVEMENT 26902 0 FMV SUB-SAHARAN AFRICA - TANZANIA GLOBAL MOVEMENT 29048 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA GLOBAL MOVEMENT 26381 0 FMV SUB-SAHARAN AFRICA - UGANDA GLOBAL MOVEMENT 25529 0 FMV SUB-SAHARAN AFRICA - KENYA GLOBAL MOVEMENT 37490 0 FMV SUB-SAHARAN AFRICA - ZIMBABWE GLOBAL MOVEMENT 24763 0 FMV SUB-SAHARAN AFRICA - MALAWI GLOBAL MOVEMENT 25071 0 FMV SUB-SAHARAN AFRICA - LESOTHO GLOBAL MOVEMENT 8264 0 FMV SUB-SAHARAN AFRICA - ZAMBIA GLOBAL MOVEMENT 25624 0 FMV SUB-SAHARAN AFRICA - LESOTHO GLOBAL MOVEMENT 35723 0 FMV SUB-SAHARAN AFRICA - TANZANIA GLOBAL MOVEMENT 12500 0 FMV SUB-SAHARAN AFRICA - UGANDA GLOBAL MOVEMENT 33074 0 FMV SUB-SAHARAN AFRICA - UGANDA RESEARCH ENGAGEMENT 33054 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 263392 0 FMV SUB-SAHARAN AFRICA - ZAMBIA RESEARCH ENGAGEMENT 48594 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 8446 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 8500 0 FMV SUB-SAHARAN AFRICA - MALAWI RESEARCH ENGAGEMENT 8500 0 FMV SUB-SAHARAN AFRICA - KENYA RESEARCH ENGAGEMENT 8500 0 FMV SUB-SAHARAN AFRICA - ZAMBIA RESEARCH ENGAGEMENT 8500 0 FMV SUB-SAHARAN AFRICA - LESOTHO RESEARCH ENGAGEMENT 8500 0 FMV SUB-SAHARAN AFRICA - KENYA RESEARCH ENGAGEMENT 65000 0 FMV SUB-SAHARAN AFRICA - NIGERIA RESEARCH ENGAGEMENT 22509 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 8759 0 FMV SUB-SAHARAN AFRICA - ZIMBABWE RESEARCH ENGAGEMENT 251473 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 99203 0 FMV SUB-SAHARAN AFRICA - ZAMBIA RESEARCH ENGAGEMENT 200000 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 295643 0 FMV SUB-SAHARAN AFRICA - SOUTH AFRICA RESEARCH ENGAGEMENT 172940 0 FMV EUROPE (INCLUDING ICELAND & GREENLAND) - UNITED KINGDOM PRODUCT INTRODUCTION AND ACCESS 65819 0 FMV SOUTH ASIA - THAILAND RESEARCH ENGAGEMENT 25000 0 FMV 36 0 0 0 0 0 0 PART I, LINE 2: WORK PLAN AND BUDGET ARE DEVELOPED; GRANT AGREEMENT IS SIGNED, FINANCIAL AND PROGRAM REPORTS ARE REVIEWED BY BOTH PROGRAM AND FINANCE STAFF PRIOR TO RELEASING ADDITIONAL FUNDS. PROGRAM STAFF CONDUCTS SITE VISITS, REVIEWS REPORTS AND IS IN DIRECT COMMUNCIATION VIA TELEPHONE AND EMAIL ON A REGULAR BASIS TO MONITOR IMPLEMENTATION OF ACTIVITES AND USE OF FUNDS FOR PROPER PURPOSES. ALL AMOUNTS ARE REPORTED IN ACCORDANCE WITH U.S.GAAP. SCHEDULE F, PART I, LINE 3A REGION: SUB-SAHARAN AFRICA - SPECIFIC TYPES OF GRANTS IN KENYA, MALAWI, NIGERIA, SOUTH AFRICA, UGANDA, TANZANIA, ZIMBABWE, ZAMBIA AND LESOTHO. 1 INTERNATIONAL AIDS VACCINE INITIATIVE 125 BROAD STREET NEW YORK NY 10004 133870223 501 (C) (3) 0 226877 FMV HIV VACCINE AND BIOM FAMILY HEALTH INTERNATIONAL 360 359 BLACKWELL STREET DURHAM NC 27701 237413005 501 (C) (3) 0 160000 FMV HIV VACCINE AND BIOM INTERNEWS 876 7TH STREET ARCATA CA 95518 943027961 501 (C) (3) 0 97665 FMV HIV VACCINE AND BIOM CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVENUE SUITE 4000 BOSTON MA 02127 271414646 501 (C) (3) 0 555472 FMV TO CREATE A PLATFORM 4 PART I, LINE 2: WORK PLAN AND BUDGET ARE DEVELOPED; GRANT AGREEMENT IS SIGNED, FINANCIAL AND PROGRAM REPORTS ARE REVIEWED BY BOTH PROGRAM AND FINANCE STAFF PRIOR TO RELEASING ADDITIONAL FUNDS. PROGRAM STAFF CONDUCTS SITE VISITS, REVIEWS REPORTS AND IS IN DIRECT COMMUNICATION VIA TELEPHONE AND EMAIL ON A REGULAR BASIS TO MONITOR IMPLEMENTATION OF ACTIVITIES AND USE OF FUNDS FOR PROPER PURPOSES. X X X X 0 0 0 0 0 0 0 1 0 MITCHELL WARREN EXECUTIVE DIRECTOR 391062 0 9750 0 0 0 13800 0 33703 0 448315 0 0 0 ERIN KIERNON CHIEF OPERATING OFFICER 253516 0 0 0 0 0 7997 0 56422 0 317935 0 0 0 ABIGAIL SMITH CHIEF FINANCIAL OFFICER 237388 0 0 0 0 0 9502 0 56422 0 303312 0 0 0 STACEY HUMPHRIES DIRECTOR, RESEARCH ENGAGEMENT 188580 0 0 0 0 0 7782 0 56222 0 252584 0 0 0 SURAJKUMAR MADOORI DIRECTOR, POLICY ADVOCACY 175549 0 0 0 0 0 7162 0 56422 0 239133 0 0 0 MANJU CHATANI-GADA DIRECTOR, PARTNERSHIPS 191190 0 0 0 0 0 7638 0 39710 0 238538 0 0 0 WANDA BUCKNER DIRECTOR, FINANCE 169312 0 0 0 0 0 6837 0 53533 0 229682 0 0 0 KENYON FARROW DIRECTOR, COMMUNICATIONS 172382 0 0 0 0 0 6126 0 20540 0 199048 0 0 0 PART I, LINE 7 SELECTED EMPLOYEES WERE PAID A PERFORMANCE BONUS DURING THE YEAR. FORM 990, PART III, LINE 3 AVAC EXPERIENCED SIGNIFICANT FEDERAL FUNDING DISRUPTIONS IN EARLY 2025 DUE TO A U.S. AGENCY FOR INTERNATIONAL DEVELOPMENT ("USAID") "STOP WORK ORDER FOR ITS COALITION TO ACCELERATE AND SUPPORT PREVENTION RESEARCH ("CASPR") PROJECT, FOLLOWED BY A GRANT TERMINATION FOR ITS MAXIMIZING OPTIONS TO ADVANCE INFORMED CHOICE FOR HIV PREVENTION ("MOSAIC") PROJECT. THIS NECESSITATED COST-CUTTING, INCLUDING STAFF REDUCTIONS, AND A SHIFT OF PROGRAM ACTIVITIES TO ALTERNATIVE FUNDING. WHILE THE CASPR STOP WORK WAS LATER CANCELED, NO NEW FUNDS HAVE BEEN OBLIGATED, SO AVAC WILL EXHAUST EXISTING DRAWN-DOWN FUNDS. AVAC, ALONG WITH ANOTHER NONPROFIT, FILED A LAWSUIT AGAINST THE GOVERNMENT, SECURING A TEMPORARY RESTRAINING ORDER AND PRELIMINARY INJUNCTION TO RELEASE FOREIGN ASSISTANCE PAYMENTS, THOUGH THE LITIGATION IS ONGOING. FORM 990, PART VI, SECTION B, LINE 11B THE DRAFT 990 WAS SHARED WITH THE AUDIT COMMITEE FOR REVIEW. AFTER THE INTERNAL REVIEW WAS COMPLETED BY THE EXECUTIVE DIRECTOR, THE CHIEF FINANCIAL OFFICER AND THE EXECUTIVE COMMITTEE, THE DRAFT WAS PRESENTED TO THE WHOLE BOARD FOR APPROVAL. FORM 990, PART VI, SECTION B, LINE 12C A CONFLICT OF INTEREST FORM IS SUBMITTED TO ALL BOARD MEMBERS; AT THE REGULAR BOARD MEETING,THE EXECUTIVE DIRECTOR REMINDS BOARD MEMBERS TO RETURN THE SIGNED FORM TO THE CHIEF FINANCIAL OFFICER; BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS IN PERSON OR VIA EMAIL PRIOR TO SIGNING THE FORM. A CONFLICT OF INTEREST FORM IS ALSO SUBMITTED TO STAFF FOR SIGNATURE. THE FORM IS SIGNED ON AN ANNUAL BASIS BY BOARD MEMBERS AND STAFF. TWO BOARD MEMBERS REVIEW ALL CONFLICT OF INTEREST FORMS; AND IN CASE OF A POTENTIAL CONFLICT OF INTEREST THE REST OF THE BOARD ENFORCE THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE DIRECTOR'S COMPENSATION PACKAGE WAS REVIEWED BY THE COMPENSATION COMMITTTEE. THE COMPENSATION COMMITTEE IS COMPOSED OF THE PRESIDENT, THE TREASURER, THE SECRETARY AND ONE ADDITIONAL BOARD MEMBER. THEY USED RELEVANT COMPENSATION SURVEY DATA FROM SIMILAR SIZE NON PROFIT ORGANIZATION TO DETERMINE THE APPROPRIATE COMPENSATION PACKAGE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION AT PRESENT DOES NOT MAKE ITS GOVERNING DOCUMENTS AVAILABLE TO THE PUBLIC. HOWEVER, THE FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE AND BY REQUEST. FORM 990, PART IX, LINE 11G FEES WERE PAID TO CONSULTANTS AND CONTRACTORS TO CONDUCT TRAINING, RESEARCH AND PROGRAM EVALUATION, ETC.